货号（Catalog No.）

CSD00440

通用名INN

Erenumab

纯度(Purity)

>95%

浓度( Concentration)

1mg/ml

Formulation

PBS buffer PH7.5

Source

CHO cells

内毒素(Endotoxin level)

Please contact with the lab for this information.

生物活性

产品描述(Description)

Erenumab (AMG-334) (INN; trade name Aimovig) is a human monoclonal antibody designed specifically to bind and antagonize the calcitonin gene-related peptide receptor (CGRPR) as a means to prevent migraines. Aimovig, as released and marketed by Novartis and Amgen, is in fact a novel therapeutic approach as the first and only FDA approved treatment specifically developed to prevent migraine by blocking the CGRP receptor, which is believed to play a critical role in migraine .

别名(Alternative names)

AMG 334,erenumab-aooe

靶点;物种(Specificity target name;species)

CALCRL/CGRP-R[Homo sapiens]

种类(Species)

Homo sapiens

受体鉴定(Receptor identification)

IgG2-lambda

化学信息

分子量(MV)

150000.00 Da

CAS

1582205-90-0

存储条件(Storage)

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4°C short term (1-2 weeks).
Store at -20 °C 12 months.
Store at -80°C long term.

Note

For research use only .